Insider Trading April 6, 2026

Chewy General Counsel Disposes $219,289 in Class A Shares

Hu Da-Wai sold 8,149 Chewy shares on April 1, 2026; analysts remain split on valuation and margin outlook

By Leila Farooq CHWY
Chewy General Counsel Disposes $219,289 in Class A Shares
CHWY

Chewy Inc. general counsel and corporate secretary Hu Da-Wai sold 8,149 shares of Class A common stock on April 1, 2026, at $26.91 per share, a transaction worth $219,289. The filing shows a mosaic of restricted stock units and performance-based awards remaining in Hu’s holdings. Meanwhile, analysts have adjusted price targets and recommendations for Chewy amid mixed views on growth and margin improvement.

Key Points

  • Hu Da-Wai, Chewy’s General Counsel and Secretary, sold 8,149 shares of Class A common stock on April 1, 2026 at $26.91 per share, totaling $219,289.
  • The Form 4 details a variety of restricted stock units and performance-based awards remaining in Hu’s holdings, including multiple grants from 2024 and 2025 and two separate performance-based award figures.
  • Analysts have issued mixed updates: RBC raised its target to $47 (Outperform), BofA cut its target to $40 (Buy), UBS lowered its target to $32 (Neutral), and TD Cowen increased its target to $42, reflecting differing views on growth and margin improvements.

Chewy Inc. (NASDAQ:CHWY) reported an insider sale by General Counsel and Secretary Hu Da-Wai. According to a Form 4 filed with the Securities and Exchange Commission, Hu sold 8,149 shares of Class A common stock on April 1, 2026, executing the shares at $26.91 apiece for a total consideration of $219,289.

The SEC filing also details Hu Da-Wai’s remaining direct holdings in various restricted stock units and performance-based awards following that sale. The filing lists 49,962 shares of Class A common stock in the form of performance-based restricted stock units; 29,856 shares in restricted stock units granted on April 1, 2024; 76,299 shares in performance-based restricted stock units; 21,906 shares in restricted stock units granted on April 1, 2025; and 10,870 shares in restricted stock units granted on April 1, 2024.

Separately, InvestingPro commentary included with the filing notes that Chewy appears undervalued at current price levels and mentions that Pro Research Reports are available for CHWY and more than 1,400 other U.S. equities. The filing itself does not attach further commentary from Chewy regarding the insider transaction.


Analyst moves and outlook

Following Chewy’s recent financial disclosures and guidance, several sell-side analysts have revised their targets and stances on the stock:

  • RBC Capital raised its price target to $47 while maintaining an Outperform rating, citing Chewy’s strong 2026 outlook and expected net sales growth of 8% to 9% year-over-year.
  • BofA Securities trimmed its price target to $40 but kept a Buy rating. The firm pointed to multiple compression as a concern even as it slightly increased fiscal 2027 revenue and EBITDA projections.
  • UBS reduced its price target to $32 and kept a Neutral rating, highlighting difficulty in improving gross margins amid a competitive environment.
  • TD Cowen raised its price target to $42, referencing Chewy’s fourth-quarter fiscal 2025 results and constructive fiscal 2026 margin guidance, and noting that EBITDA exceeded consensus by about 1%.

These analyst actions underscore differing interpretations of Chewy’s near-term sales momentum and margin trajectory.


What the filing shows and what it does not

The Form 4 provides a precise snapshot of the sale and the composition of the executive’s equity holdings, but it does not state the motivation behind the sale or any planned future transactions. It also does not offer commentary on how management views the company’s valuation or capital allocation beyond what is reflected in public filings and analyst reports.

Investors and market participants often monitor insider transactions for signals about executive sentiment. In this instance, the filing documents the sale amount, the exact number of shares sold, the per-share price, and the remaining restricted and performance-based awards held by the executive.


Bottom line

Hu Da-Wai’s April 1 sale of 8,149 Class A shares for $219,289 is now on record via the SEC Form 4. At the same time, analysts continue to express a range of views on Chewy’s valuation and margin outlook, reflected in recent price target revisions and maintained ratings.

Risks

  • Uncertainty about Chewy’s ability to materially improve gross margins in a competitive market - this concern was explicitly cited by UBS and has direct implications for consumer discretionary and e-commerce profit dynamics.
  • Potential multiple compression affecting valuation despite revenue and EBITDA revisions - BofA cited multiple compression as a reason for lowering its price target, which could influence investor sentiment in the broader equities market.
  • The Form 4 does not disclose motives for the insider sale, leaving ambiguity for investors reading insider transactions as signals; this uncertainty can affect market perception in the financial markets and corporate governance assessments.

More from Insider Trading

GlobalFoundries CLO Disposes $21,480 in Shares as Company Advances Legal and Capital Moves Apr 6, 2026 Huron Director Executes Pre-Planned Sale of Shares as Company Posts Q4 Beat, Guidance Range Draws Scrutiny Apr 6, 2026 Huron Director Debra Zumwalt Disposes $21,578 in Shares Via Pre-Arranged Plan Apr 6, 2026 Japan Post Holdings Disposes of 20,100 Aflac Shares in $2.2M Sale Apr 6, 2026 Insider Increase: Jorey Chernett Buys $253,800 of AirSculpt Technologies Stock Apr 6, 2026